Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 8;31(11):1776-1791.
doi: 10.1016/j.chom.2023.10.015.

Trained immunity: Target for prophylaxis and therapy

Affiliations
Free article
Review

Trained immunity: Target for prophylaxis and therapy

Athanasios Ziogas et al. Cell Host Microbe. .
Free article

Abstract

Trained immunity is a de facto memory for innate immune responses, leading to long-term functional reprogramming of innate immune cells. In physiological conditions, trained immunity leads to adaptive states that enhance resistance against pathogens and contributes to immunosurveillance. Dysregulated trained immunity can however lead either to defective innate immune responses in severe infections or cancer or to inflammatory and autoimmune diseases if trained immunity is inappropriately activated. Here, we review the immunological and molecular mechanisms that mediate trained immunity induction and propose that trained immunity represents an important target for prophylactic and therapeutic approaches in human diseases. On the one hand, we argue that novel approaches that induce trained immunity may enhance vaccine efficacy. On the other hand, induction of trained immunity in cancer, and inhibition of exaggerated induction of trained immunity in inflammatory disorders, are viable targets amenable for new therapeutic approaches.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.G.N. and W.M. are scientific founders of TTxD and BioTRIP. M.G.N. is the scientific founder of Lemba. R.v.d.M., W.J.M.M., and M.G.N. have patents related to this manuscript. These include the following patent applications: WO2022268913A1 (R.v.d.M. and W.J.M.M.), WO2022268913A1 (R.v.d.M. and W.J.M.M.), WO2023046931A1 (R.v.d.M. and W.J.M.M.), WO2022198101A1 (W.J.M.M.), WO2019103998A2 (W.J.M.M. and M.G.N.), and WO2019100044A1 (W.J.M.M. and M.G.N.).

LinkOut - more resources